A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers
Not Applicable
Terminated
- Conditions
- Venous Stasis Ulcer
- Interventions
- Device: PriMatrixDevice: PriMatrix AgProcedure: moist wound therapy
- Registration Number
- NCT01612806
- Lead Sponsor
- Integra LifeSciences Corporation
- Brief Summary
To evaluate the effectiveness of PriMatrix, PriMatrix Ag, and Standard of Care in the treatment of venous leg ulcers (VLUs).
- Detailed Description
Healing percentages
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
- Men or women ≥ 18 years of age
- Ankle-brachial index (ABI) > 0.80
- Study wound 2-64 cm2 surface area
- Wound does not exhibit a greater than 50% reduction in surface area during the screening period
Exclusion Criteria
- Suspected or confirmed signs/symptoms of wound infection
- Hypersensitivity to bovine collagen
- Body Mass Index (BMI) ≥ 45
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description PriMatrix PriMatrix PriMatrix Dermal Repair Scaffold PriMatrix Ag moist wound therapy PriMatrix Ag Antimicrobial Dermal Repair Scaffold PriMatrix Ag PriMatrix Ag PriMatrix Ag Antimicrobial Dermal Repair Scaffold PriMatrix moist wound therapy PriMatrix Dermal Repair Scaffold Standard of Care moist wound therapy Standard of Care Moist Wound Therapy
- Primary Outcome Measures
Name Time Method Percent of VLUs healed by week 12 post-randomization 12 weeks
- Secondary Outcome Measures
Name Time Method Cost of treatment 12 weeks
Trial Locations
- Locations (5)
Caribbean Clinical Trials
🇵🇷San Juan, Puerto Rico
Dr. Pila Metropolitan Hospital Wound Healing Center
🇵🇷Ponce, Puerto Rico
Doctors' Center Hospital of San Juan
🇵🇷San Juan, Puerto Rico
Wound and Ulcer Care Clinic of San Juan
🇵🇷San Juan, Puerto Rico
Wilma N. Vazquez Hospital
🇵🇷Vega Baja, Puerto Rico